The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
27.84
-0.31 (-1.10%)
Jan 2, 2026, 4:00 PM EST - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $962.74 million as of January 5, 2026. Its market cap has decreased by -5.18% in one year.
Market Cap
962.74M
Enterprise Value
1.27B
1-Year Change
-5.18%
Ranking
Category
Stock Price
$27.84
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $962.74M, an increase of 127.86%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 962.74M | -1.14% |
| Dec 31, 2025 | 973.81M | 6.90% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |